L1CAM and neoplasm: To go beyond the sensitivity of bioluminescent imaging and investigate phenotypic differences between tumor-infiltrating T cells (TILs) from the different treatment groups, we treated a new cohort of SK-N-BE(2) tumor-bearing mice with different L1CAM-specific CAR T cell subsets.